Literature DB >> 718983

Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay.

C Largman, J W Brodrick, M C Geokas, J H Johnson.   

Abstract

A specific radioimmunoassay for human pancreatic anionic trypsin has been developed. The trypsin employed as radioiodinated tracer in the assay was inactivated with tosyl-L-lysine chloromethyl ketone in order to prevent binding of the tracer to the serum inhibitors alpha1-antitrypsin and alpha2-macroglobulin. A normal serum level of immunoreactive anionic trypsin of 5.45 ng/ml was determined. The results of experiments in which serum was fractionated by Sephadex G-200 gel filtration suggest that essentially all of the immunoreactive material in normal human serum is trypsinogen. This finding implies that a small fraction of the zymogens synthesized in the pancreas are released directly into the circulation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718983     DOI: 10.1016/0304-4165(78)90299-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Molecular form of pancreatic elastase 1 in human plasma.

Authors:  S Hayakawa; T Hayakawa; T Kondo; T Shibata; S Naruse
Journal:  Int J Pancreatol       Date:  1992-02

2.  Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.

Authors:  H C Ryley; P G Robinson; Y Yamashiro; D M Bradley
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

3.  Identification of a defence mechanism in vivo against the leakage of enterokinase into the blood.

Authors:  D A Grant; A I Magee; D Meeks; C Regan; D R Bainbridge; J Hermon-Taylor
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

Review 4.  Pancreatic Proteolytic Enzymes and Cancer: New Support for an Old Theory.

Authors:  Linda L Isaacs
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.